AAAAAA

   
Results: 1-15 |
Results: 15
Localized and systemic scleroderma show different histological responses to methotrexate therapy
Authors: Seyger, MMB van den Hoogen, FHJ van Vlijmen-Willems, IMJJ van de Kerkhof, PCM de Jong, EMGJ
Citation: Mmb. Seyger et al., Localized and systemic scleroderma show different histological responses to methotrexate therapy, J PATHOLOGY, 193(4), 2001, pp. 511-516
High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis - Results of an open study to assess feasibility, safety, and efficacy
Authors: Verburg, RJ Kruize, AA van den Hoogen, FHJ Fibbe, WE Petersen, EJ Preijers, F Sont, JK Barge, RMY Bijlsma, JWJ van de Putte, LB Breedveld, FC van Laar, JM
Citation: Rj. Verburg et al., High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis - Results of an open study to assess feasibility, safety, and efficacy, ARTH RHEUM, 44(4), 2001, pp. 754-760
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres
Authors: Della Rossa, A Valentini, G Bombardieri, S Bencivelli, W Silman, AJ D'Angelo, S Cerinic, MM Belch, JF Black, CM Becvar, R Bruhlman, P Cozzi, F Czirjak, L Drosos, AA Dziankowska, B Ferri, C Gabrielli, A Giacomelli, R Hayem, G Inanc, M McHugh, NJ Nielsen, H Scorza, R Tirri, E van den Hoogen, FHJ Vlachoyiannopoulos, PG
Citation: A. Della Rossa et al., European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres, ANN RHEUM D, 60(6), 2001, pp. 585-591
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes
Authors: Valentini, G Della Rossa, A Bombardieri, S Bencivelli, W Silman, AJ D'Angelo, S Cerinic, MM Belch, JF Black, CM Bruhlmann, P Czirjak, L De Luca, A Drosos, AA Ferri, C Gabrielli, A Giacomelli, R Hayem, G Inanc, M McHugh, NJ Nielsen, H Rosada, M Scorza, R Stork, J Sysa, A van den Hoogen, FHJ Vlachoyiannopoulos, PJ
Citation: G. Valentini et al., European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes, ANN RHEUM D, 60(6), 2001, pp. 592-598
Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjogren's syndrome
Authors: Zandbelt, MM van den Hoogen, FHJ de Wilde, PC van den Berg, PJS Schneider, HGF van de Putte, LBA
Citation: Mm. Zandbelt et al., Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjogren's syndrome, ANN RHEUM D, 60(5), 2001, pp. 511-513
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment
Authors: den Broeder, AA van den Hoogen, FHJ van de Putte, LBA
Citation: Aa. Den Broeder et al., Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment, ANN RHEUM D, 60(5), 2001, pp. 538-539
Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement
Authors: van Heereveld, HAEM Laan, RFJM van den Hoogen, FHJ Malefijt, MCD Novakova, IRO van de Putte, LBA
Citation: Haem. Van Heereveld et al., Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement, ANN RHEUM D, 60(10), 2001, pp. 974-976
Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein
Authors: Degen, WGJ Pieffers, M Welin-Henriksson, E van den Hoogen, FHJ van Venrooij, WJ Raats, JMH
Citation: Wgj. Degen et al., Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein, EUR J IMMUN, 30(10), 2000, pp. 3029-3038
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis
Authors: Kroot, EJJA de Jong, BAW van Leeuwen, MA Swinkels, H van den Hoogen, FHJ van't Hof, M van de Putte, LBA van Rijswijk, MH van Venrooij, WJ van Riel, PLCM
Citation: Ejja. Kroot et al., The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis, ARTH RHEUM, 43(8), 2000, pp. 1831-1835
A patient with a severe scleroedema diabeticorum, partially responding to low-dose methotrexate
Authors: Seyger, MMB van den Hoogen, FHJ de Mare, S van Haelst, U de Jong, EMGJ
Citation: Mmb. Seyger et al., A patient with a severe scleroedema diabeticorum, partially responding to low-dose methotrexate, DERMATOLOGY, 198(2), 1999, pp. 177-179
Dystonia; a central nervous system presentation of Sjogren's syndrome
Authors: van den Berg, JSP Horstink, MWIM van den Hoogen, FHJ Oyen, WJG
Citation: Jsp. Van Den Berg et al., Dystonia; a central nervous system presentation of Sjogren's syndrome, MOVEMENT D, 14(2), 1999, pp. 374-375
Education of rheumatic disorders at Dutch medical schools
Authors: Jacobs, JCG Rasker, JJ van den Hoogen, FHJ Metz, JCM
Citation: Jcg. Jacobs et al., Education of rheumatic disorders at Dutch medical schools, J RHEUMATOL, 26, 1999, pp. 14-16
Systemic sclerosis: New insights in autoimmunity
Authors: Kaal, SEJ van den Hoogen, FHJ de Jong, EMGJ Vietor, HE
Citation: Sej. Kaal et al., Systemic sclerosis: New insights in autoimmunity, P SOC EXP M, 222(1), 1999, pp. 1-8
Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients
Authors: Rodenburg, RJT van den Hoogen, FHJ Barrera, P van Venrooij, WJ van de Putte, LBA
Citation: Rjt. Rodenburg et al., Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients, ANN RHEUM D, 58(10), 1999, pp. 648-652
Peripheral blood monocytes of rheumatoid arthritis patients do not expresselevated TNF alpha, IL-1 beta, and IL-8 mRNA levels. A comparison of monocyte isolation procedures
Authors: Rodenburg, RJT van den Hoogen, FHJ van de Putte, LBA van Venrooij, WJ
Citation: Rjt. Rodenburg et al., Peripheral blood monocytes of rheumatoid arthritis patients do not expresselevated TNF alpha, IL-1 beta, and IL-8 mRNA levels. A comparison of monocyte isolation procedures, J IMMUNOL M, 221(1-2), 1998, pp. 169-175
Risultati: 1-15 |